Menu Close

Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options

Citation

Dube, Karine; Campbell, Danielle; Perry, Kelly; Kanazawa, John; Saberi, Parya; Sauceda, John; Poteat, Tonia; & Evans, David (Online ahead of print). Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options. AIDS Research and Human Retroviruses.

Abstract

BACKGROUND: A growing body of research is beginning to elucidate reasons people living with HIV (PLWHIV) might prefer oral daily antiretroviral treatment (ART) compared to emerging long-acting ART (LA-ART) or HIV remission strategies under investigation. Our objective is to provide qualitative insights into the reasons why PLWHIV might prefer one of these HIV control therapies over the others.

URL

http://dx.doi.org/10.1089/aid.2020.0107

Reference Type

Journal Article

Journal Title

AIDS Research and Human Retroviruses

Author(s)

Dube, Karine
Campbell, Danielle
Perry, Kelly
Kanazawa, John
Saberi, Parya
Sauceda, John
Poteat, Tonia
Evans, David

Year Published

Online ahead of print

Reference ID

13086